Viatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline EstimatesZacks Investment Research • 05/06/24
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 05/02/24
Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental HealthPRNewsWire • 05/01/24
Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United StatesPRNewsWire • 04/01/24
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its PipelinePRNewsWire • 03/27/24
Idorsia and Viatris successfully close the transaction for the global research and development collaborationGlobeNewsWire • 03/18/24
Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form ViatrisPRNewsWire • 03/11/24